brl 42810 has been researched along with Liver Failure in 5 studies
Liver Failure: Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lamivudine (LMV) is the only nucleoside analogue approved for the treatment of chronic hepatitis B (CHB)." | 7.72 | Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure. ( Ayres, A; Bartholomeusz, A; Lam, KC; Lau, G; Lee, JY; Locarnini, S, 2003) |
| "Lamivudine (LMV) is the only nucleoside analogue approved for the treatment of chronic hepatitis B (CHB)." | 3.72 | Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure. ( Ayres, A; Bartholomeusz, A; Lam, KC; Lau, G; Lee, JY; Locarnini, S, 2003) |
| " Penciclovir is predominantly eliminated unchanged by the kidney, partly by active tubular excretion and has a terminal phase elimination half-life (t1/2 beta) of between 2 and 2." | 2.39 | The clinical pharmacokinetics of famciclovir. ( Gill, KS; Wood, MJ, 1996) |
| "Lamivudine 3 mg/kg was administered on a compassionate-use basis for 14-36 months." | 1.31 | Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children. ( Bar-Nathan, N; Ben-Ari, Z; Dinari, G; Mor, E; Shapira, R; Sokal, EM; Tur-Kaspa, R, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayres, A | 1 |
| Bartholomeusz, A | 1 |
| Lau, G | 1 |
| Lam, KC | 1 |
| Lee, JY | 1 |
| Locarnini, S | 1 |
| Gill, KS | 1 |
| Wood, MJ | 1 |
| Piqueras, B | 1 |
| Salcedo, M | 1 |
| Bañares, R | 1 |
| García-Durán, F | 1 |
| Baños, E | 1 |
| de Diego, A | 1 |
| Roldán, P | 1 |
| Cos, E | 1 |
| Clemente, G | 1 |
| Myers, RP | 1 |
| Chaudhary, R | 1 |
| Fonseca, K | 1 |
| Lee, SS | 1 |
| Shapira, R | 1 |
| Mor, E | 1 |
| Bar-Nathan, N | 1 |
| Sokal, EM | 1 |
| Tur-Kaspa, R | 1 |
| Dinari, G | 1 |
| Ben-Ari, Z | 1 |
1 review available for brl 42810 and Liver Failure
| Article | Year |
|---|---|
The clinical pharmacokinetics of famciclovir.
Topics: 2-Aminopurine; Antiviral Agents; Area Under Curve; Famciclovir; Half-Life; Herpes Zoster; Herpesviru | 1996 |
4 other studies available for brl 42810 and Liver Failure
| Article | Year |
|---|---|
Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Famciclov | 2003 |
[Famciclovir plus interferon in the treatment of a patient with chronic hepatitis B and severe liver failure].
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis, Chr | 1997 |
Fatal hepatic decompensation in a patient with hepatitis B cirrhosis following famciclovir withdrawal.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Fatal Outcome; Hepatitis B; Humans; Liver Cirrh | 2000 |
Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children.
Topics: 2-Aminopurine; Adolescent; Alanine Transaminase; Antiviral Agents; Child; Child, Preschool; Cystic F | 2001 |